Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (232) 232
life sciences & biomedicine (221) 221
humans (214) 214
infectious diseases (207) 207
female (185) 185
male (180) 180
adult (169) 169
immunology (130) 130
hiv infections - drug therapy (126) 126
hiv (122) 122
middle aged (117) 117
biological and medical sciences (113) 113
medical sciences (112) 112
virology (104) 104
aids/hiv (101) 101
cd4 lymphocyte count (100) 100
risk factors (88) 88
viral diseases (87) 87
antiviral agents (82) 82
human viral diseases (79) 79
viral diseases of the lymphoid tissue and the blood. aids (75) 75
cohort studies (74) 74
prospective studies (68) 68
hiv infections - complications (67) 67
viral load (62) 62
pharmacology. drug treatments (58) 58
aids (57) 57
antibiotics. antiinfectious agents. antiparasitic agents (55) 55
hiv infection (53) 53
human immunodeficiency virus--hiv (53) 53
anti-hiv agents - therapeutic use (52) 52
europe (50) 50
antiretroviral therapy (49) 49
incidence (49) 49
microbiology (48) 48
drug therapy (46) 46
mortality (45) 45
europe - epidemiology (43) 43
hiv infections - immunology (43) 43
antiretroviral therapy, highly active (42) 42
hiv infections - virology (42) 42
disease progression (39) 39
highly active antiretroviral therapy (37) 37
hiv infections - mortality (37) 37
immunodeficiencies (34) 34
immunodeficiencies. immunoglobulinopathies (34) 34
immunopathology (34) 34
treatment outcome (34) 34
abridged index medicus (33) 33
hiv infections - epidemiology (33) 33
antiretroviral drugs (32) 32
hiv infections (32) 32
prognosis (30) 30
anti-retroviral agents - therapeutic use (28) 28
medicin och hälsovetenskap (28) 28
acquired immune deficiency syndrome--aids (27) 27
infections (27) 27
research (27) 27
610 medicine & health (26) 26
aged (26) 26
cd4 antigen (26) 26
drug therapy, combination (26) 26
adolescent (25) 25
epidemiology (25) 25
hiv-1 (25) 25
antiretrovirals (23) 23
care and treatment (23) 23
hepatitis c (23) 23
hiv patients (23) 23
young adult (23) 23
health aspects (22) 22
antiretroviral agents (21) 21
follow-up studies (21) 21
general & internal medicine (21) 21
human immunodeficiency virus (21) 21
proportional hazards models (21) 21
analysis (20) 20
medicine, general & internal (20) 20
pharmacology & pharmacy (20) 20
hepatitis (19) 19
hiv infections - diagnosis (19) 19
medical research (19) 19
time factors (19) 19
cardiovascular disease (18) 18
complications and side effects (18) 18
tenofovir (18) 18
anti-hiv agents - adverse effects (17) 17
research article (17) 17
cardiovascular diseases (16) 16
clinic for infectious diseases (16) 16
comorbidity (16) 16
hiv-1 - drug effects (16) 16
acquired immunodeficiency syndrome - drug therapy (15) 15
anti-hiv agents - administration & dosage (15) 15
dosage and administration (15) 15
fundamental and applied biological sciences. psychology (15) 15
hiv protease inhibitors - therapeutic use (15) 15
hiv/aids (15) 15
medicine (15) 15
risk assessment (15) 15
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text The relationship between smoking, current CD4, viral load and cancer in persons living with HIV
by Mocroft, Amanda and RESPOND study group
AIDS (London), ISSN 0269-9370, 12/2020, Volume Publish Ahead of Print
Index Medicus | AIDS/HIV
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Association Between Antiretroviral Exposure and Renal Impairment Among HIV-Positive Persons With Normal Baseline Renal Function: the D:A:D Study
by Lene Ryom and Amanda Mocroft and Ole Kirk and Signe W. Worm and David A. Kamara and Peter Reiss and Michael Ross and Christoph A. Fux and Philippe Morlat and Olivier Moranne and Colette Smith and Jens D. Lundgren and D A D Study Grp and D:A:D Study Group
The Journal of infectious diseases, ISSN 0022-1899, 5/2013, Volume 207, Issue 9, pp. 1359 - 1369
T lymphocytes | Hypertension | HIV/AIDS | Antiretrovirals | Renal function | Infectious diseases | HIV | AIDS | Hepatitis B virus | Kidney diseases | Diseases | eGFR | chronic kidney disease | ART | lopinavir | nephrotoxicity | atazanavir | tenofovir | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Glomerular Filtration Rate | Prospective Studies | Humans | Middle Aged | Anti-Retroviral Agents - adverse effects | Male | Renal Insufficiency - epidemiology | Withholding Treatment | Incidence | Renal Insufficiency - chemically induced | Anti-Retroviral Agents - administration & dosage | Adult | Female | HIV Infections - drug therapy | Cohort Studies | Antiviral agents | Complications and side effects | Chronic kidney failure | Demographic aspects | Research | Drug therapy | Risk factors | HIV seropositivity | Index Medicus | Abridged Index Medicus | Life Sciences | Microbiology and Parasitology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Contemporary protease inhibitors and cardiovascular risk
by Lundgren, Jens and Mocroft, Amanda and Ryom, Lene
Current opinion in infectious diseases, ISSN 0951-7375, 12/2017, Volume 31, Issue 1, pp. 8 - 13
HIV | protease inhibitors | cardiovascular disease | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | HIV Protease Inhibitors - adverse effects | Risk Assessment | Humans | Antiretroviral Therapy, Highly Active - adverse effects | Atazanavir Sulfate - adverse effects | HIV Protease Inhibitors - therapeutic use | Atazanavir Sulfate - therapeutic use | Ritonavir - adverse effects | HIV Infections - complications | Cardiovascular Diseases - epidemiology | Ritonavir - therapeutic use | HIV Infections - drug therapy | Cardiovascular Diseases - chemically induced | Darunavir - adverse effects | Antiretroviral Therapy, Highly Active - methods | Darunavir - therapeutic use | Physiological aspects | Complications and side effects | HIV patients | Protease inhibitors | Cardiovascular diseases | Risk factors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe
by Mocroft, Amanda and Reiss, Peter and Gasiorowski, Jacek and Ledergerber, Bruno and Kowalska, Justyna and Chiesi, Antonio and Gatell, Jose and Rakhmanova, Aza and Johnson, Margaret and Kirk, Ole and Lundgren, Jens and EuroSIDA Study Grp and EuroSIDA Study Group
Journal of acquired immune deficiency syndromes (1999), ISSN 1525-4135, 2010, Volume 55, Issue 2, pp. 262 - 270
CD4 | Non-AIDS-defining illnesses | HIV | Mortality | AIDS-defining illnesses | Morbidity | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Age Factors | Antiretroviral Therapy, Highly Active - mortality | Epidemiology - statistics & numerical data | Humans | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Europe - epidemiology | Male | CD4 Lymphocyte Count | Incidence | Acquired Immunodeficiency Syndrome - mortality | Female | Poisson Distribution | Acquired Immunodeficiency Syndrome - complications | Antiretroviral drugs | Acquired immune deficiency syndrome--AIDS | Drug therapy | Human immunodeficiency virus--HIV | Risk factors | Index Medicus | AIDS/HIV
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Airflow limitation in people living with HIV and matched uninfected controls
by Ronit, Andreas and Lundgren, Jens and Afzal, Shoaib and Benfield, Thomas and Roen, Ashley and Mocroft, Amanda and Gerstoft, Jan and Nordestgaard, Børge G and Vestbo, Jørgen and Nielsen, Susanne D and Copenhagen Co-morbidity HIV and Copenhagen Co-morbidity in HIV infection (COCOMO) study group
Thorax, ISSN 0040-6376, 05/2018, Volume 73, Issue 5, pp. 431 - 438
COPD epidemiology | immunodeficiency | Life Sciences & Biomedicine | Respiratory System | Science & Technology | HIV Infections - blood | Prospective Studies | Humans | Middle Aged | Risk Factors | Male | CD4 Lymphocyte Count | Case-Control Studies | Forced Expiratory Volume | Vital Capacity | Tobacco Smoking - physiopathology | Adult | Female | HIV Infections - physiopathology | Comorbidity | Lung diseases | Infections | Morbidity | Studies | Airway management | Tobacco | Infectious diseases | Hospitals | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Data collection | Population | Chronic obstructive pulmonary disease | Drug therapy | Age | Smoking | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Development and validation of a cycle‐specific risk score for febrile neutropenia during chemotherapy cycles 2–6 in patients with solid cancers: The CSRFENCE score
by Aagaard, Theis and Reekie, Joanne and Roen, Ashley and Daugaard, Gedske and Specht, Lena and Sengeløv, Henrik and Mocroft, Amanda and Lundgren, Jens and Helleberg, Marie
International journal of cancer, ISSN 0020-7136, 01/2020, Volume 146, Issue 2, pp. 321 - 328
infection | risk score | prediction | cancer | febrile neutropenia | prophylaxis | chemotherapy | g‐csf | Statistical analysis | Risk groups | Prophylaxis | Risk reduction | Derivation | Radiation therapy | Taxane | Regression analysis | Risk analysis | Patients | Risk factors | Chemotherapy | Prediction models | Platinum | Poisson density functions | Risk management | Leukocytes (granulocytic) | Neutropenia
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text The benefits and risks of PrEP and kidney function
by Mocroft, Amanda and Ryom, Lene
The lancet HIV, ISSN 2352-3018, 2016, Volume 3, Issue 11, pp. e501 - e502
Infectious Disease | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Index Medicus | AIDS/HIV
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Influence of Hepatitis C Virus Infection on HIV-1 Disease Progression and Response to Highly Active Antiretroviral Therapy
by Jürgen K. Rockstroh and Amanda Mocroft and Vincent Soriano and Cristina Tural and Marcello H. Losso and Andrzej Horban and Ole Kirk and Andrew Phillips and Bruno Ledergerber and Jens Lundgren and EuroSIDA Study Group
The Journal of infectious diseases, ISSN 0022-1899, 9/2005, Volume 192, Issue 6, pp. 992 - 1002
HIV/AIDS | Highly active antiretroviral therapy | Coinfection | RNA | HIV | Liver | AIDS | Infections | Hepacivirus | HIV 1 | Diseases | Fundamental and applied biological sciences. Psychology | Miscellaneous | Viral hepatitis | Infectious diseases | Microbiology | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Virology | HIV Infections - virology | Humans | Middle Aged | Risk Factors | Male | RNA, Viral - blood | CD4 Lymphocyte Count | Disease Progression | Antiretroviral Therapy, Highly Active | HIV Infections - immunology | Hepatitis C - immunology | HIV-1 - isolation & purification | Hepatitis C Antibodies - blood | Hepatitis C - mortality | HIV Infections - complications | Survival Analysis | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Hepatitis C - complications | Cohort Studies | Antiviral agents | Dosage and administration | Liver diseases | Diagnosis | Drug therapy | Hepatitis C | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Cascade of care and factors associated with virological suppression among HIV-positive persons linked to care in the Test and Keep in Care (TAK) project
by Kowalska, Justyna D and Ankiersztejn-Bartczak, Magdalena and Shepherd, Leah and Mocroft, Amanda
Infection, ISSN 0300-8126, 8/2018, Volume 46, Issue 4, pp. 533 - 540
Linkage | Medicine & Public Health | HIV | Viral suppression | General Practice / Family Medicine | Infectious Diseases | Internal Medicine | Cascade of care | Antiretroviral therapy | Life Sciences & Biomedicine | Science & Technology | HIV Infections - epidemiology | HIV Infections - virology | Humans | Kaplan-Meier Estimate | Proportional Hazards Models | Male | Treatment Outcome | CD4 Lymphocyte Count | Factor Analysis, Statistical | Viral Load | Antiretroviral Therapy, Highly Active | HIV Infections - diagnosis | Ambulatory Care Facilities | Biomarkers | Poland | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Disease Management | Prevention | Antiviral agents | Care and treatment | Usage | Risk assessment | Analysis | Diagnosis | HIV (Viruses) | Anti-HIV agents | Integrase | Antiretroviral drugs | Test facilities | Sexually transmitted diseases--STD | Statistical models | Syphilis | Human immunodeficiency virus--HIV | Health risks | Histocompatibility antigen HLA | Ribonucleic acid--RNA | Patients | Index Medicus | Original Paper
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Impact of Risk Factors for Specific Causes of Death in the First and Subsequent Years of Antiretroviral Therapy Among HIV-Infected Patients
by Suzanne M. Ingle and Margaret T. May and M. John Gill and Michael J. Mugavero and Charlotte Lewden and Sophie Abgrall and Gerd Fätkenheuer and Peter Reiss and Michael S. Saag and Christian Manzardo and Sophie Grabar and Mathias Bruyand and David Moore and Amanda Mocroft and Timothy R. Sterling and Antonella D'Arminio Monforte and Victoria Hernando and Ramon Teira and Jodie Guest and Matthias Cavassini and Heidi M. Crane and Jonathan A. C. Sterne and Antiretroviral Therapy Cohort and Antiretroviral Therapy Cohort Collaboration and for the Antiretroviral Therapy Cohort Collaboration
Clinical infectious diseases, ISSN 1058-4838, 7/2014, Volume 59, Issue 2, pp. 287 - 297
HIV/AIDS | Antiretrovirals | HIV infections | Causes of death | HIV | Predisposing factors | AIDS | Grants | Cardiovascular diseases | Mortality rates | Viral load | antiretroviral therapy | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Antiviral agents | Immunopathology | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Immunodeficiencies. Immunoglobulinopathies | Immunodeficiencies | Antibiotics. Antiinfectious agents. Antiparasitic agents | HIV Infections - epidemiology | Humans | Middle Aged | Risk Factors | Europe - epidemiology | Male | Cause of Death | Antiretroviral Therapy, Highly Active | Young Adult | Adolescent | Adult | Female | HIV Infections - drug therapy | HIV Infections - mortality | Aged | North America - epidemiology | Cohort Studies | Complications and side effects | Care and treatment | HIV infection | Mortality | Risk factors | Antiretroviral drugs | Disease transmission | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Index Medicus | cause-specific mortality
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study
by Mocroft, Amanda, Prof and Lundgren, Jens D, Prof and Ross, Michael, MD and Fux, Christoph A and Reiss, Peter, Prof and Moranne, Olivier, MD and Morlat, Philippe, MD and Monforte, Antonella d'Arminio, Prof and Kirk, Ole, DMSc and Ryom, Lene, MD and Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) Study and Data Collection Adverse Events
The lancet HIV, ISSN 2352-3018, 2016, Volume 3, Issue 1, pp. e23 - e32
Infectious Disease | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Prospective Studies | Tenofovir - adverse effects | Renal Insufficiency, Chronic - etiology | Tenofovir - therapeutic use | United States | Anti-HIV Agents - adverse effects | Europe | Humans | Middle Aged | Male | Atazanavir Sulfate - adverse effects | Renal Insufficiency, Chronic - physiopathology | Atazanavir Sulfate - therapeutic use | Young Adult | Glomerular Filtration Rate - drug effects | Adolescent | HIV Infections - complications | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Australia | Index Medicus | AIDS/HIV | Life Sciences | Human health and pathology | Infectious diseases | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights